US EMS Protocol Census
Statewide

Tennessee Emergency Medical Services

May be outdated143 dose entries42 drugs1 documentTNeffective 2024-01-0192% machine-parsed of 143

Tennessee Emergency Medical Services (TN) carries 42 drugs across 143 dose entries in its current published protocol, effective 2024-01-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses42

Acetaminophen

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 325–1000 mg PO not captured standing page 143 · source
Other peds 10–15 mg/kg PO not captured standing page 143 · source

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
SVT adult 12 mg IV not captured standing pages 22, 27 · source
SVT peds 0.1 mg/kg IV not captured standing pages 22, 27 · source

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
CHF / pulmonary edema adult 2.5 mg NEB not captured standing page 45 · source
Crush injury adult 5 mg NEB not captured standing page 139 · source
Respiratory distress adult 2.5 mg NEB not captured standing pages 59, 210 · source
Respiratory distress peds 2.5 mg NEB not captured standing pages 59, 210 · source

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 300 mg IV not captured standing page 28 · source
Other peds 5 mg/kg IV not captured standing page 28 · source
Wide-complex tachycardia adult 150–300 mg IV/IO not captured standing pages 21, 27 · source
Wide-complex tachycardia peds 5 mg/kg IV/IO not captured standing pages 21, 27 · source
VF / pulseless VT adult 300 mg IV/IO not captured standing page 25 · source
VF / pulseless VT peds 5 mg/kg IV/IO not captured standing page 25 · source

Amyl Nitrite

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 ampule NEB not captured standing page 132 · source

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 324 mg PO not captured standing pages 16, 18 · source

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 0.5 mg IV not captured standing page 15 · source
Bradycardia peds 0.02 mg/kg IV not captured standing page 15 · source
Nerve agent exposure peds 0.05 mg/kg IV/IO/IM not captured standing page 39 · source

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Crush injury adult 1 g IV not captured standing page 140 · source
Crush injury peds 20 mg/kg IV not captured standing page 140 · source
Hyperkalemia adult 500 mg IV not captured standing pages 20, 24, 25 · source
Hyperkalemia peds 20 mg/kg IV not captured standing pages 20, 24, 25 · source
Tricyclic overdose adult 500 mg IV not captured standing pages 20, 24, 25 · source
Tricyclic overdose peds 20 mg/kg IV not captured standing pages 20, 24, 25 · source

Calcium Gluconate

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2.5 g TOP not captured standing page 130 · source

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Crush injury adult 25 g IV not captured standing page 139 · source
Crush injury peds 0.5 g/kg IV not captured standing page 139 · source
Hypoglycemia adult 12.5–25 g IV not captured standing pages 56, 64, 204, 210, 211 · source
Hypoglycemia peds 2 mL/kg IV not captured standing pages 56, 64, 204, 210, 211 · source

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation peds 0.1 mg/kg IV not captured standing page 40 · source
Procedural sedation adult 2–5 mg IV not captured standing pages 22, 23, 27 · source
Procedural sedation peds 0.1 mg/kg IV not captured standing pages 22, 23, 27 · source
Seizure adult 2–5 mg IV/IO not captured standing pages 31, 32, 39, 60, 61 · source
Seizure peds 0.1 mg/kg IV/IO not captured standing pages 31, 32, 39, 60, 61 · source
Seizure peds 0.2–0.5 mg/kg PR not captured standing page 61 · source

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Atrial fibrillation with RVR adult 0.25 mg/kg IV not captured standing page 148 · source

Dimercaprol

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 3 mg/kg IM not captured standing page 128 · source

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 25–50 mg IV/IM not captured standing pages 46, 210 · source
Anaphylaxis peds 1 mg/kg IV/IM not captured standing pages 46, 210 · source
Dystonic reaction adult 25 mg IV/IM not captured standing page 121 · source

Droperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IV/IM not captured standing page 146 · source
Nausea / vomiting adult 0.625–2.5 mg IV/IM not captured standing page 146 · source
Nausea / vomiting peds 0.015–0.1 mg/kg IV/IM not captured standing page 146 · source

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3–0.5 mg IM not captured standing page 46 · source
Anaphylaxis adult 0.3–0.5 mg IV/IO not captured standing page 46 · source
Anaphylaxis peds 0.01 mg/kg IM not captured standing page 46 · source
Anaphylaxis peds 0.01 mg/kg IV/IO not captured standing page 46 · source
Bradycardia adult 2–10 mcg IV not captured standing page 15 · source
Cardiac arrest adult 1 mg IV/IO not captured standing pages 15, 20, 24, 25, 26 · source
Cardiac arrest peds 0.01 mg/kg IV/IO not captured standing pages 15, 20, 24, 25, 26 · source
Croup peds 1 mg NEB not captured standing pages 50, 210 · source
Respiratory distress adult 0.3–0.5 mg IM not captured standing page 59 · source
Respiratory distress peds 0.01 mg/kg IM not captured standing page 59 · source

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 1–2 mg IV/IM not captured standing page 15 · source
Beta-blocker / calcium-channel-blocker overdose peds 0.5–1 mg IV/IM not captured standing page 15 · source
Hypoglycemia adult 1–2 mg IM not captured standing pages 60, 64 · source
Hypoglycemia peds 0.5–1 mg IM not captured standing pages 60, 64 · source

Haloperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IM not captured standing page 147 · source

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 g IV not captured standing pages 126, 144 · source

Ibuprofen

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 400–800 mg PO not captured standing page 142 · source
Other adult 600 mg PO not captured standing page 160 · source
Other peds 10 mg/kg PO not captured standing page 160 · source
Other peds 5–10 mg/kg PO not captured standing page 142 · source

Insulin

IndicationPopulationDoseRouteRepeatStandingSource
Crush injury adult 10 unit IV not captured standing page 139 · source
Crush injury peds 0.2 unit/kg IV not captured standing page 139 · source

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 1.5–2 mg/kg IV not captured standing page 205 · source
Agitation peds 1.5–2 mg/kg IV not captured standing page 205 · source
RSI induction adult 1–2 mg/kg IV not captured standing page 206 · source
RSI induction peds 1–2 mg/kg IV not captured standing page 206 · source
Seizure adult 1 mg/kg IV/IM not captured standing page 206 · source
Seizure peds 1 mg/kg IV/IM not captured standing page 206 · source

Ketorolac

IndicationPopulationDoseRouteRepeatStandingSource
Severe pain adult 10–30 mg IV/IM not captured standing page 143 · source

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–1.5 mg/kg IV/IO not captured standing page 141 · source
Other adult 1–1.5 mg/kg IV/IO not captured standing page 141 · source
Other peds 0.5 mg/kg IV/IO not captured standing page 141 · source
Other peds 0.5 mg/kg IV/IO not captured standing page 141 · source

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Seizure adult 1–2 mg IV not captured standing pages 31, 32, 39, 60, 61 · source
Seizure adult 2–4 mg IM not captured standing pages 31, 39, 60 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 31, 32, 39, 60, 61 · source

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 6 g IV not captured standing page 98 · source
Respiratory distress adult 1–2 g IV not captured standing page 59 · source
VF / pulseless VT adult 1–2 g IV not captured standing pages 23, 24, 25 · source

Methylene Blue

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–2 mg/kg IV not captured standing page 136 · source

Methylergonovine

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 0.2 mg IM not captured standing page 91 · source

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 62.5–125 mg IV not captured standing pages 46, 211 · source
Respiratory distress adult 62.5–125 mg IV not captured standing pages 59, 211 · source

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2–5 mg not captured not captured standing pages 114, 117 · source
Agitation peds 0.1 mg/kg not captured not captured standing pages 114, 117 · source
Agitation peds 0.1 mg/kg IV not captured standing page 40 · source
Procedural sedation adult 2–5 mg IV not captured standing pages 22, 23, 27 · source
Procedural sedation peds 0.1 mg/kg IV not captured standing pages 22, 23, 27 · source
Seizure adult 2–5 mg IV/IO/IM not captured standing pages 31, 39, 60 · source
Seizure peds 0.2 mg/kg IM not captured standing pages 32, 39, 61 · source
Seizure peds 0.3 mg/kg IN not captured standing pages 32, 39, 61 · source

Misoprostol

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 400 mcg PR not captured standing page 91 · source

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 0.4–2 mg IV/IN not captured standing page 14 · source
Cardiac arrest peds 0.1 mg/kg IV/IO/IM/IN not captured standing page 20 · source
Hypothermia adult 0.4 mg IV/IO/IM/IN not captured standing page 35 · source
Hypothermia peds 0.1 mg/kg IV/IO/IM/IN not captured standing page 35 · source
Opioid overdose adult 0.4 mg IV/IN not captured standing page 167 · source
Opioid overdose peds 0.1 mg/kg IV/IN not captured standing page 167 · source
Other adult 0.4–2 mg IV/IO/IM/IN not captured standing page 31 · source
Other adult 0.4–2 mg IV/IO/IM/IN not captured standing page 64 · source
Other peds 0.1 mg/kg IV/IO/IM/IN not captured standing page 31 · source
Other peds 0.1 mg/kg IV/IO/IM/IN not captured standing page 64 · source
Seizure adult 0.4–2 mg IV/IO/IM/IN not captured standing page 60 · source
Seizure peds 0.1 mg/kg IV/IO/IM/IN not captured standing page 60 · source

Nerve Agent Antidote Kit

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 kit IM not captured standing page 38 · source
Other adult 1 kit IM not captured standing page 138 · source
Other adult 3 kits IM not captured standing page 38 · source
Other adult 3 kits IM not captured standing page 138 · source

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 16, 17, 18 · source
CHF / pulmonary edema adult 0.4 mg SL not captured standing page 45 · source
Other adult 0.4 mg SL not captured standing page 55 · source

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 2–4 mg IV not captured standing pages 44, 211 · source
Nausea / vomiting adult 8 mg PO not captured standing page 44 · source
Nausea / vomiting peds 0.15 mg/kg IV not captured standing pages 44, 211 · source
Nausea / vomiting peds 4 mg PO not captured standing page 44 · source

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 1 tube PO not captured standing page 56 · source
Hypoglycemia peds 1 tube PO not captured standing page 56 · source

Oxytocin

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 10 unit IM not captured standing page 91 · source
Obstetric hemorrhage adult 30–40 unit IV not captured standing page 91 · source

Pralidoxime

IndicationPopulationDoseRouteRepeatStandingSource
Organophosphate poisoning adult 600 mg IV not captured standing page 138 · source
Organophosphate poisoning adult 600 mg IM not captured standing page 138 · source
Organophosphate poisoning peds 15 mg/kg IV not captured standing page 138 · source
Organophosphate poisoning peds 15 mg/kg IM not captured standing page 138 · source
Other adult 20–50 mg/kg IV not captured standing page 138 · source
Other adult 600 mg IM not captured standing page 138 · source
Other peds 15 mg/kg IM not captured standing page 138 · source
Other peds 20–50 mg/kg IV not captured standing page 138 · source

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Crush injury adult 50 mEq IV not captured standing page 139 · source
Crush injury peds 1 mEq/kg IV not captured standing page 139 · source
Hyperkalemia adult 1 mEq/kg IV/IO not captured standing pages 20, 24, 25 · source
Hyperkalemia peds 1 mEq/kg IV/IO not captured standing pages 20, 24, 25 · source
Other adult 1–2 mEq/kg IV/IO not captured standing pages 20, 24, 25 · source
Tricyclic overdose adult 1 mEq/kg IV/IO not captured standing pages 20, 24, 25 · source
Tricyclic overdose peds 1 mEq/kg IV/IO not captured standing pages 20, 24, 25 · source

Sodium Nitrite

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 300 mg IV not captured standing page 132 · source

Tetracaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 drop not captured not captured standing page 122 · source
Other adult 2 drop not captured not captured standing page 134 · source

Tranexamic Acid

IndicationPopulationDoseRouteRepeatStandingSource
Trauma / hemorrhage adult 2 g IV not captured standing page 143 · source
Trauma / hemorrhage peds 20 mg/kg IV not captured standing page 143 · source